Today: 20 March 2026
USA Rare Earth stock jumps on $1.6B U.S. backing — PIPE closing date and dilution in focus
27 January 2026
2 mins read

USA Rare Earth stock jumps on $1.6B U.S. backing — PIPE closing date and dilution in focus

New York, Jan 26, 2026, 18:03 EST — After-hours

  • USA Rare Earth shares climbed 7.9% to $26.72 during regular trading but slipped lower in after-hours action
  • Company revealed a non-binding U.S. funding plan linked to the CHIPS program alongside a $1.5 billion PIPE
  • Traders are keeping an eye on the Jan. 28 PIPE closing deadline and the strides made toward finalizing government agreements

Shares of USA Rare Earth (USAR) climbed 7.9% to finish Monday at $26.72, before slipping roughly 1% in after-hours trading. The move followed the company’s announcement of a government-supported financing strategy linked to its U.S. rare-earths expansion. Investing.com

The company announced it has signed a non-binding letter of intent (LOI) with the U.S. Department of Commerce’s CHIPS program, outlining $277 million in proposed federal funding and a proposed $1.3 billion senior secured loan. Additionally, it secured a $1.5 billion private investment in public equity (PIPE) led by Inflection Point. CEO Barbara Humpton said the funds will help build a domestic “rare earth value chain.” Commerce Secretary Howard Lutnick described the initiative as a step toward making supply chains “no longer reliant on foreign nations.” GlobeNewswire

Washington is ramping up efforts to boost domestic supply of critical minerals vital for defense and high-tech manufacturing, as China remains the leading player in processing and magnets. The Commerce Department’s latest investment fits into a wider federal push to cut dependence on China for materials essential to weapons systems, electronics, and energy infrastructure. AP News

Reuters reported the Commerce Department plans to take a 10% stake in the Oklahoma-based firm, marking another move in a growing series of U.S. investments in miners. This follows earlier stakes in MP Materials, Lithium Americas, and Trilogy Metals. But unlike MP Materials’ previous deal, Reuters noted that USA Rare Earth’s package lacks any government price floor or guarantee. Humpton told investors the company pitches its value with a stark question: “What would be the cost of having access to nothing?” Reuters

A securities filing revealed USA Rare Earth inked a purchase agreement for roughly 69.8 million shares at $21.50 each in the PIPE. The company anticipates closing the private placement by Jan. 28, pending usual conditions. The filing also outlined that the planned government funding will roll out in phases based on milestones. It specified several hurdles before final agreements, such as raising non-federal capital and locking in memoranda of understanding with semiconductor users, among other criteria.

The stock saw volatile moves, fluctuating from $25.80 up to $32.07 during the session. It exchanged about 122 million shares—far exceeding its typical volume—before slipping back toward the mid-$20s. The Motley Fool

A PIPE involves a private investment in a publicly traded company, usually through new shares sold to institutions at a negotiated price. These deals often include warrants, granting the holder the option to purchase stock later at a set price.

Investors are drawn by something simple: a rare-earth “mine-to-magnet” strategy backed by government funds, in an industry that’s had trouble financing large U.S. ventures without federal aid.

But it’s a double-edged sword. The Commerce deal remains just an LOI, while the equity components—the PIPE along with shares and warrants reserved for the government—signal potential dilution if the funding package goes through as planned.

Markets are zeroing in on two key developments: whether the PIPE deal wraps up by Jan. 28, and any filings indicating the Commerce LOI is advancing to definitive agreements — something the company anticipates happening this quarter.

Stock Market Today

  • Kessler Topaz Meltzer & Check Files Securities Fraud Class Action Against Soleno Therapeutics
    March 20, 2026, 1:23 PM EDT. Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) concerning purchases of SLNO stock between March 26 and November 4, 2025. The lawsuit alleges that Soleno made materially false statements and omissions about safety concerns in its Phase 3 clinical trial for diazoxide choline extended-release tablets used to treat hyperphagia linked to Prader-Willi syndrome. The firm claims the company concealed issues relating to excess fluid retention in trial participants. Investors have until May 5, 2026, to seek lead plaintiff status. The complaint is pending in the U.S. District Court for the Northern District of California under case number 3:26-cv-01979. Investors who suffered losses are urged to contact the law firm for legal options at no cost.
JPMorgan stock price watch: JPM eases after-hours as Trump lawsuit and Fed meeting crowd the tape
Previous Story

JPMorgan stock price watch: JPM eases after-hours as Trump lawsuit and Fed meeting crowd the tape

AppLovin stock rises after Needham upgrade sets $700 target as Feb. 11 earnings loom
Next Story

AppLovin stock rises after Needham upgrade sets $700 target as Feb. 11 earnings loom

Go toTop